Home › Abdominal Aortic Aneurysm › Virginia › Norfolk
Abdominal Aortic Aneurysm clinical trials in Norfolk, VA
7 studies for Abdominal Aortic Aneurysm are looking for participants at sites in and around Norfolk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Nectero EAST System Clinical Study
RecruitingPhase 2/3
- Sentara Health, Norfolk
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Recruiting
- Sentara Hospitals, Norfolk
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
Recruiting
- Sentara Norfolk General Hospital, Norfolk
AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation
RecruitingObservational studyHealthy volunteers welcome
- Innovation Health Services, Norfolk
Terumo Aortic Global Endovascular Registry
RecruitingObservational study
- Sentara Heart Hospital, Norfolk
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
RecruitingObservational study
- Sentara Heart Hospital, Norfolk
- Sentara Heart Hospital, Norfolk
Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
Recruiting
- Sentara Health Research Center, Norfolk
Abdominal Aortic Aneurysm trials in other cities
- Boston, MA8 studies
- Philadelphia, PA7 studies
- Pittsburgh, PA6 studies
- Washington, DC5 studies
- St. Louis, MO5 studies
- Durham, NC5 studies
- Houston, TX5 studies
- Cleveland, OH5 studies
- Portland, OR4 studies
- Chicago, IL4 studies
- Seattle, WA4 studies
- Mountain View, CA4 studies
Other studies in Norfolk
- Breast Cancer15 studies
- Prostate Cancer8 studies
- Bladder Cancer8 studies
- Ovarian Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Heart Failure7 studies
- Cancer (all types)7 studies
- Cardiovascular Disease7 studies
- Spinal Muscular Atrophy6 studies
- Obesity5 studies
- Triple-Negative Breast Cancer5 studies
- Acute Lymphoblastic Leukemia5 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.